Abstract
Intrauterine growthrestriction (IUGR) increases the risk of type 2 diabetes developing in adulthood. In previous studies that used bilateral uterine artery ligation in a rat model of IUGR, age-associated decline in glucose homeostasis and islet function was revealed. To elucidate mechanisms contributing to IUGR pathogenesis, the islet transcriptome was sequenced from 2-week-old rats, when in vivo glucose tolerance is mildly impaired, and at 10 weeks of age, when rats are hyperglycemic and have reduced β-cell mass. RNA sequencing and functional annotation with Ingenuity Pathway Analysis revealed temporal changes in IUGR islets. For instance, gene expression involving amino acid metabolism was significantly reduced primarily at 2 weeks of age, but ion channel expression, specifically that involved in cell-volume regulation, was more disrupted in adult IUGR islets. Additionally, we observed alterations in the microenvironment of IUGR islets with extracellular matrix genes being significantly increased at 2 weeks of age and significantly decreased at 10 weeks. Specifically, hyaluronan synthase 2 expression and hyaluronan staining were increased in IUGR islets at 2 weeks of age (P < 0.05). Mesenchymal stromal cell-derived factors that have been shown to preserve islet allograft function, such as Anxa1, Cxcl12, and others, also were increased at 2 weeks and decreased in adult islets. Finally, comparisons of differentially expressed genes with those of type 2 diabetic human islets support a role for these pathways in human patients with diabetes. Together, these data point to new mechanisms in the pathogenesis of IUGR-mediated islet dysfunction in type 2 diabetes.
| Original language | English |
|---|---|
| Pages (from-to) | 1035-1049 |
| Number of pages | 15 |
| Journal | Endocrinology |
| Volume | 159 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2018 |
Bibliographical note
Publisher Copyright:Copyright © 2018 Endocrine Society.
Funding
Financial Support: The experiments performed in this study were funded by National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant T32HD60556 and National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK55704 (to R.A.S.).
| Funders | Funder number |
|---|---|
| R.A.S. | |
| National Institutes of Health (NIH) | |
| National Institute of Diabetes and Digestive and Kidney Diseases | R01DK055704 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | T32HD60556 |
ASJC Scopus subject areas
- Endocrinology